Antimicrobial photosensitive reactions

Archives of Internal Medicine

Volumn 158, Issue 18, 1998, Pages 1993-2000

  Vassileva, Snejina G ^a   Mateev, Grisha ^a   Parish, Lawrence Charles ^b,c  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORPROMAZINE; CIMETIDINE; GRISEOFULVIN; HYDRALAZINE; HYDROCHLOROTHIAZIDE; ISONIAZID; METHYLDOPA; MINOCYCLINE; ORAL CONTRACEPTIVE AGENT; PENICILLAMINE; PROCAINAMIDE; PSORALEN; QUINIDINE; QUINOLONE; SALAZOSULFAPYRIDINE; SULFONAMIDE; TETRACYCLINE;

ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; HUMAN; LUPUS ERYTHEMATOSUS; PHOTOALLERGY; PHOTOSENSITIVITY DISORDER; PHOTOSENSITIZATION; PHOTOTOXICITY; PREDICTION; PRIORITY JOURNAL; REVIEW; SKIN ABSORPTION; TISSUE INJURY; ULTRAVIOLET RADIATION;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; PHOTOSENSITIVITY DISORDERS;

EID: 0032511742     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.18.1993     Document Type: Review

References (64)

1. Hakim RE. Rediscovery of a treatment for vitiligo. Clio Med. 1969;4:277-289.
2. Hudson JB. Plant photosensitizes with antiviral properties. Antiviral Res. 1989;12:55-74.
3. Hudson JB, Graham EA, Harris L, et al. The unusual UVA-dependent antiviral properties of the furocoumarin, coriandrin. Photochem Photobiol. 1993;57:491-496.
4. Hudson JB, Zhou J, Chen J, et al. Hypocrellin, from Hypocrella babuase, is phototoxic to human immunodeficiency virus. Photochem Photobiol. 1994;60:253-255.
5. Fabbri P, Panconesi E. Erythmamultiforme ("minus" and "maius") and drug intake. Clin Dermatol. 1993;4:479-489.
6. Baes H. Photosensitivity caused by nalidixic acid. Dermatologica. 1968;136:61-64.
7. Orentreich N, Harber LC, Tromovitch TA. Photosensitivity and photo-onycholysis due to demethylchlortetracycline. Arch Dermatol. 1961;83:68-75.
8. Blank H, Cullen S, Catalano PM. Photosensitivity studies with demethylchlortetracycline and doxycycline. Arch Dermatol. 1968;97:1-2.
9. Hasan T, Kochevar E, McAuliff DJ, et al. Mechanism of tetracycline phototoxicity. J Invest Dermatol. 1984;83:179-183.
10. Stahlmann R. Safety profile of the quinolones. J Antimicrob Chemother. 1990;20(suppl D):31-44.
11. Bowie WB, Willetts V, Jewesson PJ. Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin. Antimicrob Agents Chemother. 1989;33:1778-1782.
12. Norrby SR, Lietman PS. Safety and tolerability of fluoroquinolones. Drugs. 1993;45(suppl 3):59-64.
13. González E, González S. Drug photosensitivity, idiopathic photodermatoses, and sunscreens. J Am Acad Dermatol. 1996;35:871-885.
14. Epstein JH. Phototoxicity and photoallergy in man. J Am Acad Dermatol. 1983;8:141-147.
15. Warin AP. The ultraviolet erythemas in man. Br J Dermatol. 1978;98:473-477.
16. Harber LC, Baer RL. Pathogenic mechanisms of drug-induced Photosensitivity. J Invest Dermatol. 1972;58:327-342.
17. Ljunggren B, Bjellerup M. Systemic drug photosensitivity. Photodermatology. 1986;3:26-35.
18. Przybilla B, Georgii A, Bergner T, et al. Demonstration of quinolone phototoxicity in vitro. Dermatologica. 1990;181:98-103.
19. Tokura Y, Iwamoto Y, Mizutani K, et al. Sparfloxacin phototoxicity: potential photoaugmentation by ultraviolet A and B sources. Arch Dermatol Res. 1996;288:45-50.
20. Emmett EA. Drug photoallergy. Int J Dermatol. 1978;17:370-379.
21. DeLeo VA, Maso MJ. Photosensitivity. In: Moschella SL, Hurley HJ, eds. Dermatology. Philadelphia, Pa: WB Saunders Co; 1992:507-531.
22. Mirensky YM, Parish LC. Photosensitivity and the quinolones. J Eur Acad Dermatol Venereol. 1995;4:1-4.
23. Toback AC, Longley J, Cardullo AC, Doddy U, Romagnoli M, DeLeo VA. Severe chronic photosensitivity in association with acquired immunodeficiency syndrome. J Am Acad Dermatol. 1986; 15:1056-1057.
24. Rich MW. Drug-induced lupus. Postgrad Med. 1996;100:299-302.
25. Cush JJ, Goldings EA. Drug-induced lupus: clinical spectrum and pathogenesis. Med Sci. 1985; 290:36-45.
26. Gould JW, Mercurio MG, Elmets CA. Cutaneous photosensitivity diseases induced by exogenous agents. J Am Acad Dermatol. 1995;33:551-573.
27. Alarcón-Segovia D, Kraus A. Drug-related lupus syndromes and their relationship to spontaneously occurring systemic lupus erythematosus. Clin Rheumatol Int Pract Res. 1991;5:1-12.
28. Shapiro LE, Knowles SR, Shear NH. Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol. 1997;133:1224-1230.
29. Laversuch CJ, Collins DA, Charles PJ, Bourke BE. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease. Br J Rheumatol. 1995;34:435-439.
30. Norris DA, Lee LA. Antibody-dependent cytotoxicity and skin disease. J Invest Dermatol. 1985; 85:165S-175S.
31. Miyagawa S, Okuchi T, Shiomi Y, Sakamoto K. Subacute cutaneous lupus erythematosus lesions precipitated by griseofulvin. J Am Acad Dermatol. 1989;21:343-346.
32. Arlett C, Earl L, Ferguson J, et al. British Photodermatology Group Workshop: predictive in vitro methods for identifying photosensitizing drugs: a report. Br J Dermatol. 1995;132:271-274.
33. Navaratnam S, Parsons BJ, Hughes JL. Laser-flash photolysis studies of benoxaprofen and its analogues, 1: yields of triplet states and singlet oxygen in acetonitrile solutions. J Photochem Photobiol A. 1993;73:97-103.
34. Iwamoto Y, Kurita A, Shimizu T, et al. DNA strand-breaking activities of quinolone antimicrobial agents under visible light irradiation. Biol Pharm Bull. 1994;17:654-657.
35. Shimoda K, Yoshida M, Wagai N, et al. Phototoxic lesions induced by quinolone antibacterial agents in auricular skin and retina of albino mice. Toxicol Pathol. 1993;21:554-561.
36. Vassileva S, Prost C. Discovering vesiculobullous drug eruptions through dermatopathologic techniques. Clin Dermatol. 1993;11:557-565.
37. Fotiades J, Soter NA, Um HW. Results of evaluation of 203 patients for photosensitivrty in a 7.3-year period. J Am Acad Dermatol. 1995;33:597-602.
38. Michel M, Dompmartin A, Moreau A, Leroy D. Contact photosensitivity to nonoxynol used in antiseptic preparations. Photodermatol Photoimmunol Photomed. 1994;10:198-201.
39. Bork K. Cutaneous Side Effects of Drugs. Philadelphia, Pa: WB Saunders Co; 1981:338-361.
40. Epstein S. Photoallergy and primary sensitivity to sulfanilamide. J Invest Dermatol. 1939;2:43-51.
41. Ortel B, Sivayathorn A, Honigsmann H. An unusual combination of phototoxicity and Stevens-Johnson syndrome due to antimalarial therapy. Dermatologica. 1989;178:39-42.
42. Gabazza EC, Taguchi O, Yamakami T, et al. Pulmonary infiltrates and skin pigmentation associated with sulfasalazine. Am J Gastroenterol. 1992; 87:1654-1657.
43. Veale DJ, Morley KD. Sulphasalazine-induced lupus in psoriatic arthritis. Br J Rheumatol. 1995; 34:383-384.
44. Dhanapaul S. DOS-induced photosensitivity with reference to six case reports. Lepr Rev. 1989;60: 147-150.
45. Lim HW, Belsito DV. Basic photobiology, phototoxicity, and photoallergy. In: Arndt KA, Leboit PE, Robinson JK, Wintroub BU, eds. Cutaneous Medicine and Surgery. Vol 1. Philadelphia, Pa: WB Saunders Co; 1997:725-731.
46. Targovnik SE, Targovnik JH. Cutaneous drug reactions in porphyrias. Clin Dermatol. 1986;4:110-117.
47. Rimington C, Morgan PN, Nicholl K, et al. Griseofulvin administration and porphyrin metabolism: a survey. Lancet. 1963;1:312-322.
48. Watson CJ, Lynch F, Bossenmaier I, Cardinal R. Griseofulvin and porphyrin metabolism: special reference to normal fecal porphyrin excretion. Arch Dermatol. 1968;98:451-468.
49. Maibach HI, Sams WM Jr, Epstein JH. Screening for drug toxicity by wave lengths greater than 3100 C. Arch Dermatol. 1967;95:12-15.
50. Frost P, Weinstein G, Gomez EC. Methacycline and demeclocycline in relation to sunlight. JAMA. 1971; 216:326-329.
51. Frost P, Weinstein G, Gomez EC. Phototoxic potential of minocycline and doxycycline. Arch Dermatol. 1972;105:681-683.
52. Bjellerup M, Ljunggren B. Differences in phototoxic potency should be considered when tetracyclines are prescribed during summertime: a study on doxycycline and lymecycline in human volunteers, using an objective method for recording erythema. Br J Dermatol. 1994;130:356-360.
53. Bjellerup M, Ljunggren B. Photohemolytic potency of tetracyclines. J Invest Dermatol. 1985; 84:262-264.
54. Piette J, Decuyper J, van de Vorst A. DNA alterations photosensitized by tetracycline and some of its derivatives. J Invest Dermatol. 1986;86:653-658.
55. Ramsay CA, Obreshkova E. Photosensitivity from nalidixicacid. Br J Dermatol. 1974;91:523-528.
56. Wolfson JS, Hooper PC. Fluoroquinoione antimicrobial agents. Clin Microbiol Rev. 1989;2:378-424.
57. Kawabe Y, Mizuno N, Shigeru S. Photoallergic reaction caused by enoxacin. Photodermatology. 1989;6:58-60.
58. Kurumaji Y, Shono M. Scarified photopatch testing in lomefloxacin photosensitivity. Contact Dermatitis. 1992;26:5-10.
59. Shelley ED, Shelley WB. The subcorneal pustular drug eruption: an example induced by norfloxacin. Cutis. 1988;42:24-27.
60. Baran R, Brun P. Photoonycholysis induced by the fluoroquinolones pefloxacine and ofloxacine: report on 2 cases. Dermatologica. 1986;173:185-188.
61. Baran R, Juhlin L. Drug-induced photo-onycholysis: three subtypes identified in a study of 15 cases. J Am Acad Dermatol. 1987;17:1012-1016.
62. Marutani K, Matsumoto M, Otabe Y, et al. Reduced phototoxicity of a fluoroquinolone antibacterial agent with a methoxy group at the 8 position in mice irradiated with long-wavelength UV light. Antimicrob Agents Chemother. 1993;37:2217-2223.
63. Fujita H, Matsuo I. In vitro phototoxic activities of new quinolone antibacterial agents: lipid peroxidative potentials. Photodermatol Photoimmunol Photomed. 1994;10:202-205.
64. Lowe NJ, Fakouhi TD, Stern RS, et al. Photoreactions with a fluoroquinolone antimicrobial: evening versus morning dosing. Clin Pharmacol Ther. 1994;56:587-591.